Eradivir to Showcase Novel Antiviral Approaches at ESCMID Global and ICAR 2026 Eradivir a clinical-stage biotechnology company focused on developing innovative therapies for infectious diseases, has announced its participation in two major international scientific conferences in 2026. The company will…
A Milestone for Keratoconus Treatment Glaukos Corporation has announced a significant regulatory and reimbursement milestone for its innovative therapy, Epioxa™ (Epioxa HD / Epioxa), designed to treat Keratoconus—a progressive and potentially sight-threatening corneal condition. The Centers for Medicare and Medicaid…
CareDx to Divest Lab Products Business for $170 Million, Reports Strong Q1 2026 Growth CareDx, Inc. has announced a definitive agreement to sell its Lab Products business to Eurobio Scientific for $170 million in cash. The decision marks a significant…
Bayer Canada Backs a Transformative Step in Medical Education Bayer Canada has announced a significant initiative to support the launch of the new School of Medicine at Simon Fraser University (SFU). This collaboration marks a major milestone in advancing healthcare…
GNQ Insilico and IBM Collaborate to Advance Precision Medicine and Clinical AI Adoption In a significant move aimed at transforming the future of healthcare and drug development, GNQ Insilico has announced a strategic collaboration with IBM. This partnership is designed…
Covalon Technologies Demonstrates Strong Momentum Across Key Healthcare Segments Covalon Technologies Ltd., a leader in advanced medical technologies, has announced a series of notable milestones that underscore its accelerating commercial momentum and expanding presence across critical healthcare segments. The company…
Atropos Health Introduces Robust Evidence Review Framework to Elevate Clinical Decision-Making In a significant step toward improving the reliability and scalability of real-world evidence (RWE), Atropos Health has announced the implementation of a comprehensive, multi-layered evidence review process. This initiative…
AACR 2026: STC-1010 Shows Safety & Early Immune Activity in MSS CRC Brenus Pharma, a clinical-stage biotechnology company based in Lyon, France, has announced the presentation of new first-in-human data for its lead immunotherapy candidate, STC-1010, at the AACR Annual…
Imperative Care Launches ADAPT 2.0 Study to Advance Stroke Treatment with Streamlined Aspiration Technique Imperative Care, a medical technology company dedicated to improving outcomes for patients with vascular diseases, has announced the enrollment of the first patients in its ADAPT…
Cryo-Cell International, Inc. Reports Fiscal First Quarter 2026 Financial Results Cryo-Cell International a pioneer in the cord blood banking industry, has announced its financial results for the first quarter of fiscal year 2026, which ended on February 28, 2026. As…
